Clinuvel Pharmaceuticals
CUV.AX
#8532
Rank
S$0.35 B
Marketcap
S$7.10
Share price
0.13%
Change (1 day)
-30.83%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2026: S$42.2 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$64.99 Million. In 2026 the company made an earning of S$42.2 Million a decrease over its 2025 earnings that were of S$43.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026S$42.2 M-2.84%
2025S$43.44 M0.26%
2024S$43.32 M11.35%
2023S$38.9 M28.31%
2022S$30.32 M22.8%
2021S$24.69 M112.63%
2020S$11.61 M-28.73%
2019S$16.29 M32.79%
2018S$12.27 M75.41%
2017S$6.99 M-332.52%
2016-S$3.01 Million-70.68%
2015-S$10.27 Million53.78%
2014-S$6.68 Million-16.1%
2013-S$7.96 Million-37.92%
2012-S$12.82 Million-18.19%
2011-S$15.67 Million25.31%
2010-S$12.51 Million-21.53%
2009-S$15.94 Million-11.27%
2008-S$17.96 Million80.4%
2007-S$9.96 Million-2.46%
2006-S$10.21 Million-5.35%
2005-S$10.79 Million60.55%
2004-S$6.72 Million97.37%
2003-S$3.41 Million50.62%
2002-S$2.26 Million121.22%
2001-S$1.03 Million254.48%
2000-S$0.29 Million